Cytek Biosciences, Inc. CTKB Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s financing cash flow?
- Cytek Biosciences, Inc. (CTKB) reported financing cash flow of $3.98M in Q1 2026.
- How has Cytek Biosciences, Inc.'s financing cash flow changed year-over-year?
- Cytek Biosciences, Inc.'s financing cash flow increased by 134.5% year-over-year, from -$11.55M to $3.98M.
- What is the long-term trend for Cytek Biosciences, Inc.'s financing cash flow?
- Over 3 years (2021 to 2024), Cytek Biosciences, Inc.'s financing cash flow has grown at a -58.0% compound annual growth rate (CAGR), from $213.56M to -$15.82M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.